Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Weight control and cancer preventive mechanisms: role of insulin growth factor-1-mediated signaling pathways.

Xie L, Wang W.

Exp Biol Med (Maywood). 2013 Feb;238(2):127-32. doi: 10.1177/1535370213477602. Review.

2.

Weight control, endocrine hormones and cancer prevention.

King B, Jiang Y, Su X, Xu J, Xie L, Standard J, Wang W.

Exp Biol Med (Maywood). 2013 May;238(5):502-8. doi: 10.1177/1535370213480695. Review.

PMID:
23856901
3.

Energy balance, physical activity, and cancer risk.

Fair AM, Montgomery K.

Methods Mol Biol. 2009;472:57-88. doi: 10.1007/978-1-60327-492-0_3. Review.

PMID:
19107429
4.

Obesity-induced metabolic stresses in breast and colon cancer.

Sung MK, Yeon JY, Park SY, Park JH, Choi MS.

Ann N Y Acad Sci. 2011 Jul;1229:61-8. doi: 10.1111/j.1749-6632.2011.06094.x. Review.

PMID:
21793840
5.

Impact of targeting insulin-like growth factor signaling in head and neck cancers.

Limesand KH, Chibly AM, Fribley A.

Growth Horm IGF Res. 2013 Oct;23(5):135-40. doi: 10.1016/j.ghir.2013.06.001. Epub 2013 Jun 29. Review.

6.

Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: potential therapeutic targets for cardiac cachexia.

Yoshida T, Tabony AM, Galvez S, Mitch WE, Higashi Y, Sukhanov S, Delafontaine P.

Int J Biochem Cell Biol. 2013 Oct;45(10):2322-32. doi: 10.1016/j.biocel.2013.05.035. Epub 2013 Jun 13. Review.

7.

Diet and cancer prevention studies in p53-deficient mice.

Hursting SD, Perkins SN, Phang JM, Barrett JC.

J Nutr. 2001 Nov;131(11 Suppl):3092S-4S. Review.

8.

New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.

Hales EC, Taub JW, Matherly LH.

Cell Signal. 2014 Jan;26(1):149-61. doi: 10.1016/j.cellsig.2013.09.021. Epub 2013 Oct 16. Review.

PMID:
24140475
9.

Mechanisms by which IGF-I may promote cancer.

Grimberg A.

Cancer Biol Ther. 2003 Nov-Dec;2(6):630-5. Review. Erratum in: Cancer Biol Ther. 2004 Feb;3(2):139.

10.

Reducing the weight of cancer: mechanistic targets for breaking the obesity-carcinogenesis link.

Hursting SD, Lashinger LM, Wheatley KW, Rogers CJ, Colbert LH, Nunez NP, Perkins SN.

Best Pract Res Clin Endocrinol Metab. 2008 Aug;22(4):659-69. doi: 10.1016/j.beem.2008.08.009. Review.

PMID:
18971125
11.

PI3K/Akt and MAPK/ERK1/2 signaling pathways are involved in IGF-1-induced VEGF-C upregulation in breast cancer.

Zhu C, Qi X, Chen Y, Sun B, Dai Y, Gu Y.

J Cancer Res Clin Oncol. 2011 Nov;137(11):1587-94. doi: 10.1007/s00432-011-1049-2. Epub 2011 Sep 9. Review.

PMID:
21904903
12.

Role of adipokines and cytokines in obesity-associated breast cancer: therapeutic targets.

Khan S, Shukla S, Sinha S, Meeran SM.

Cytokine Growth Factor Rev. 2013 Dec;24(6):503-13. doi: 10.1016/j.cytogfr.2013.10.001. Epub 2013 Oct 21. Review.

PMID:
24210902

Supplemental Content

Support Center